Treatment of Mycobacterium fortuitum pulmonary infection with “transfer factor” (TF): New methodology for evaluating TF potency and predicting clinical response

Levin, 1970, 67, 821 Spitler, 1972, J. Clin. Invest., 51, 3216, 10.1172/JCI107148 Basten, 1978, 83 Arala-Chaves, 1978, 35 Fudenberg, 1980, 34, 3 Fudenberg, 1980, 391 Wilson, 1982, Immunol. Today Lawrence, 1969, Adv. Immunol., 11, 195, 10.1016/S0065-2776(08)60480-0 Wilson, 1981, Lymphokines, 4, 107 Borkowsky, 1979, J. Immunol., 123, 1741, 10.4049/jimmunol.123.4.1741 Sirianni, 1979, Clin. Immunol. Immunopathol., 14, 300, 10.1016/0090-1229(79)90156-9 Metcalf, 1981, Amer. J. Med., 71, 485, 10.1016/0002-9343(81)90186-8 Welch, 1976, 399 1979, 626 Wilson, 1979, J. Lab. Clin. Med., 93, 800 Kyong, 1980, Amer. J. Med., 68, 955, 10.1016/0002-9343(80)90230-2 Wolinsky, 1968, Amer. Rev. Resp. Dis., 97, 1032 Feld, 1976, Arch. Int. Med., 136, 67, 10.1001/archinte.1976.03630010051009 Simon, 1981, Clin. Immunol. Immunopathol., 20, 123, 10.1016/0090-1229(81)90169-0 Thestrup-Pedersen, 1974, Acta Allergol., 29, 101, 10.1111/j.1398-9995.1974.tb01462.x Rocklin, 1975, 436